Streetbeat News

Analyst Ratings

CDTX

HC Wainwright & Co. analyst Ed Arce maintains a Buy rating on Cidara Therapeutics (CDTX) with a maintained price target of $6.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 6:20 pm

COTY

DA Davidson analyst Linda Bolton Weiser has maintained a Buy rating on Coty (NYSE:COTY) and kept the price target at $17.5.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 6:19 pm

ELF

DA Davidson analyst Linda Bolton Weiser maintains a Buy rating on e.l.f. Beauty (NYSE:ELF) and keeps the price target at $220.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 6:17 pm

IONQ

QBTS

RGTI

Needham analyst Quinn Bolton initiated coverage on D-Wave Quantum Inc (NYSE:QBTS) with a Buy rating and a price target of $2.5, highlighting its standout position in the commercial quantum computing industry through its quantum annealing technology. D-Wave's focus on commercial applications and revenue from commercial customers sets it apart from competitors like IonQ, Inc (NYSE:IONQ) and Rigetti Computing, Inc (NASDAQ:RGTI), which rely more on academic and government funding. Bolton emphasizes the transformative potential of quantum computing and D-Wave's leadership in commercializing annealing technology, with plans to expand into gate model quantum computing.

Portfolio Pulse from Anusuya Lahiri

April 08, 2024 | 6:16 pm

REAX

JonesTrading analyst Matthew Erdner has maintained a Buy rating on Real Brokerage (NASDAQ:REAX) with a maintained price target of $4.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 6:16 pm

AS

Amer Sports' stock trades lower following a downgrade by Bernstein from Outperform to Market Perform, with a reduced price target from $18.5 to $16.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 6:14 pm

FC

Barrington Research analyst Alexander Paris maintains an Outperform rating on Franklin Covey (NYSE:FC) with a $45 price target.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 6:13 pm

UI

BWS Financial analyst Hamed Khorsand maintains a Buy rating on Ubiquiti (NYSE:UI) with a $160 price target, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 6:12 pm

GTX

BWS Financial analyst Hamed Khorsand maintains a Buy rating on Garrett Motion (NASDAQ:GTX) and keeps the price target at $15.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 6:11 pm

DXCM

Investor Business Daily's Swingtrader has named DexCom (DXCM) as a 'Buy'.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 6:10 pm